In merging, the two charities will be able to use the shared expertise of each organisation. JDRF provides support and funding to world-class research trials including artificial pancreas treatments and research into finding a cure for type 1 diabetes.
INPUT is a diabetes technology advocacy charity that has helped people in the UK with getting access to beneficial new technology such as insulin pumps, continuous glucose monitors (CGMs) and flash glucose monitoring (FreeStyle Libre). The two charities also share the same mission in working to improve lives of people with type 1 diabetes.
Before the merger, Lesley Jordans was the CEO of INPUT and she now works as Senior Technology Access Specialist at JDRF. She stated: “We bring value in providing individual, personal advice to people with type 1 diabetes from a technology perspective.
“We are excited by the pace of emerging new technologies and how we can best expand our services to continue helping people access what is currently available and what will become available in the near future.”
INPUT was founded in 1998 and became a charity in 2013 and JDRF was founded in 1970.
Karen Addington, the UK Chief Executive of JDRF said: “Ours is an ideal charity merger. Lesley and I have known each other for over a decade and have worked closely together on many issues.
“Our two charities have similar aims; to improve the treatment of type 1 diabetes through research and by helping people access the technology to enable them to best manage their condition. We bring complementary expertise that together will increase our collective impact.”